DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs

References

• Baize S. Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus. Curr Opin Viro. 2015;10:70–6. doi:10.1016/j.coviro.2015.01.008.
   PubMed Web of Science ®Google Scholar
• Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of Zaire Ebola virus disease in Guinea. N Eng J Med. 2014;371:1418–25. doi:10.1056/NEJMoa1404505.
   PubMed Web of Science ®Google Scholar
• Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in West African sub-region: an overview. J Vector Borne Diseases. 2007;44:1–11.
   PubMedGoogle Scholar
• Dupuy LC, Schmaljohn CS. DNA vaccines for biodefense. Expert Rev Vaccines. 2009;8:1739–54. doi:10.1586/erv.09.132.
   PubMed Web of Science ®Google Scholar
• Broderick KE, Khan AS, Sardesai NY. DNA vaccination in skin enhanced by electroporation. Methods Mol Biol. 2014;1143:123–30. doi:10.1007/978-1-4939-0410-5_8.
   PubMedGoogle Scholar
• Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS, Yan J, Morrow MP, Patel A, Kobinger GP, et al. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther. 2011;18:258–65. doi:10.1038/gt.2010.137.
   PubMed Web of Science ®Google Scholar
• Diehl MC, Lee JC, Daniels SE, Tebas P, Khan AS, Giffear M, Sardesai NY, Bagarazzi ML. Tolerability of intramuscular and intradermal delivery by CELLECTRA((R)) adaptive constant current electroporation device in healthy volunteers. Hum Vaccin Immunother. 2013;9:2246–52. doi:10.4161/hv.24702.
   PubMed Web of Science ®Google Scholar
• Hannaman D, Dupuy LC, Ellefsen B, Schmaljohn CS. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. Vaccin. 2016;34:3607–12. doi:10.1016/j.vaccine.2016.04.077.
   Web of Science ®Google Scholar
• Hooper JW, Moon JE, Paolino KM, Newcomer R, McLain DE, Josleyn M, Hannaman D, Schmaljohn C. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation. Clin Microbiol Infect. 2014;20(Suppl 5):110–7. doi:10.1111/1469-0691.12553.
   PubMed Web of Science ®Google Scholar
• Schmaljohn CS, Spik KW, Hooper JW. DNA vaccines for HFRS: laboratory and clinical studies. Virus Re. 2014;187:91–6. doi:10.1016/j.virusres.2013.12.020.
   PubMed Web of Science ®Google Scholar
• Cashman KA, Broderick KE, Wilkinson ER, Shaia CI, Bell TM, Shurtleff AC, Spik KW, Badger CV, Guttieri MC, Sardesai NY, et al. Enhanced efficacy of a Codon-optimized DNA vaccine encoding the glycoprotein precursor gene of Lassa virus in a guinea pig disease model when delivered by dermal electroporation. Vaccines (Basel. 2013;1:262–77. doi:10.3390/vaccines1030262.
   PubMedGoogle Scholar
• Grant-Klein RJ, Altamura LA, Badger CV, Bounds CE, Van Deusen NM, Kwilas SA, Vu HA, Warfield KL, Hooper JW, Hannaman D, et al. Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges. Hum Vaccin Immunother. 2015;11:1991–2004. doi:10.1080/21645515.2015.1039757.
   PubMed Web of Science ®Google Scholar
• Grant-Klein RJ, Van Deusen NM, Badger CV, Hannaman D, Dupuy LC, Schmaljohn CS. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge. Hum Vaccin immunother. 2012;8:1703–6. doi:10.4161/hv.21873.
   PubMed Web of Science ®Google Scholar
• Bell TM, Shaia CI, Bearss JJ, Mattix ME, Koistinen KA, Honnold SP, Zeng X, Blancett CD, Donnelly GC, Shamblin JD, et al. Temporal progression of lesions in guinea pigs infected with Lassa virus. Vet Pathol. 2017;54(3):549–562. doi:10.1177/0300985816677153.
   PubMed Web of Science ®Google Scholar
• Twenhafel NA, Shaia CI, Bunton TE, Shamblin JD, Wollen SE, Pitt LM, Sizemore DR, Ogg MM, Johnston SC. Experimental aerosolized guinea pig-adapted Zaire ebolavirus (variant: Mayinga) causes lethal pneumonia in guinea pigs. Vet Pathol. 2015;52:21–5. doi:10.1177/0300985814535612.
   PubMed Web of Science ®Google Scholar
• Cashman KA, Broderick KE, Wilkinson ER, Shaia CI, Bell TM, Shurtleff AC, Spik KW, Badger CV, Guttieri MC, Sardesai NY, et al. Enhanced efficacy of a codon-optimized DNA vaccine encoding the glycoprotein precursor gene of Lassa virus in a guinea pig disease model when delivered by dermal electroporation. Vaccine. 2013;1:262–77. doi:10.3390/vaccines1030262.
   PubMedGoogle Scholar
• Cashman KA, Smith MA, Twenhafel NA, Larson RA, Jones KF, Allen RD, 3rd, Dai D, Chinsangaram J, Bolken TC, Hruby DE, et al. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Res. 2011;90:70–9. doi:10.1016/j.antiviral.2011.02.012.
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol. 2003;163:2347–70. doi:10.1016/S0002-9440(10)63591-2.
   PubMed Web of Science ®Google Scholar
• Walker DH, Wulff H, Lange JV, Murphy FA. Comparative pathology of Lassa virus infection in monkeys, guinea-pigs, and Mastomys natalensis. Bull World Health Organ. 1975;52:523–34.
   PubMed Web of Science ®Google Scholar
• Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, Deubel V. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J Immunol. 2004;172:2861–9. doi:10.4049/jimmunol.172.5.2861.
   PubMed Web of Science ®Google Scholar
• Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol. 2003;170:2797–801. doi:10.4049/jimmunol.170.6.2797.
   PubMed Web of Science ®Google Scholar
• Grant-Klein RJ, Van Deusen NM, Badger CV, Hannaman D, Dupuy LC, Schmaljohn CS. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge. Hum Vaccin Immunother. 2012;8:1703–6. doi:10.4161/hv.21873.
   PubMed Web of Science ®Google Scholar